Biotechnology 2012 Congress Concludes in Cuba

Biotechnology 2012 Congress Concludes in Cuba Havana, Mar 8. – With two symposia on hepatitis B infections and cancer treatments, the International Congress Biotechnology-Havana 2012 will conclude in this capital on Thursday.

The scientific agenda of the event also includes presentations on the integration of genomics, proteomics and bioinformatics, and posters related to the topics.

Nearly 600 specialists from 41 nations attended the event at Havana's Conventions Center, where they received updates about research works and clinical trials on vaccines against different kinds of tumors, as well as against HIV/AIDS and dengue.

Dr. Peter Agre, a professor at Duke University in Durham, North Carolina, and 2003 Nobel Chemistry Prize winner for his research on aquaporins (certain types of channels in cell membranes), highlighted Cuba's achievements in the eradication of malaria.

This is a result of the Revolution, a very effective achievement I would like to learn about and it is linked to high technology developed in the country, he said.

"We have much to learn from Cubans", said Agre on Wednesday at a press conference.(Prensa Latina)